The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma

Authors:
  • GOG.J. Ossenkoppele
    G.J. Ossenkoppele
  • ARA.A.P.M. van Riet
    A.A.P.M. van Riet
  • FRF.F.H. Rutten
    F.F.H. Rutten

Abstract
No abstract available